Register of patients with thoracic tumors
Official title: Thoracic Tumours Register
Run by Spanish Lung Cancer Group · NCT02941458 · Data updated 2026-11-12
This study is collecting information from patients with lung cancer and other chest tumors to see how different treatments can be tailored to help them feel better and live longer.
Quick facts
| Study type | Observational |
|---|---|
| Sex | All |
| Enrollment | 10000 (estimated) |
| Sponsor | Spanish Lung Cancer Group Academic / other |
| Locations | 79 sites (Ferrol, A Coruña and 78 other locations) |
| Status | Recruiting |
| Started | July 21, 2016 |
| Main results expected | December 30, 2030 |
| Study ends | December 30, 2031 |
| Registry record updated | April 23, 2026 |
| Trial ID | NCT02941458 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are patients diagnosed with thoracic tumors, regardless of whether they are receiving active treatment or palliative care.
✕Probably not a fit
Patients with tumors outside of the thoracic region will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational, multicenter study aims to collect and analyze data from patients diagnosed with lung cancer and other thoracic tumors. It focuses on individualizing treatment based on predictive markers for response to chemotherapy and molecular inhibitors. The study will gather information both retrospectively and prospectively from clinical histories to explore epidemiological and therapeutic factors related to thoracic tumors. The ultimate goal is to improve treatment outcomes and prognosis for patients suffering from these conditions.
Why it matters
Potential benefit: If successful, this study could lead to improved treatment strategies and better prognoses for patients with lung cancer and other thoracic tumors.
How similar studies have gone: Other studies focusing on the centralization of care and multidisciplinary treatment strategies for lung cancer have shown promise, indicating that this approach may yield beneficial results.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients with thoracic disease, treated with an active treatment or not treated (only palliative care) Exclusion Criteria: * Patients with other type of tumours
Where it's running
-
Complejo Hospitalario Universitario de Ferrol
Ferrol, A Coruña, Spain Recruiting -
Complejo Hospitalario Universitario de Albacete
Albacete, Albacete, Spain Recruiting -
H. Virgen de los Lirios
Alcoy, Alicante, Spain Recruiting -
Hospital General de Alicante
Alicante, Alicante, Spain Recruiting -
Hospital de Elche
Elche, Alicante, Spain Recruiting -
Hospital General de Elda
Elda, Alicante, Spain Recruiting
Show 44 more locations
-
H. Germans Trias i Pujol
Badalona, Barcelona, Spain Recruiting -
Clinica Tres Torres
Barcelona, Barcelona, Spain Recruiting -
IOB Hospital Quirón Salud Barcelona
Barcelona, Barcelona, Spain Recruiting -
HM Hospital Ntra. Sra. de la Esperanza
Barcelona, Barcelona, Spain Recruiting -
Hospital de La Santa Creu I Sant Pau
Barcelona, Barcelona, Spain Recruiting -
Hospital de Granollers
Granollers, Barcelona, Spain Recruiting -
Hospital de Mataró
Mataró, Barcelona, Spain Recruiting -
Consorci Sanitari de Terrassa
Terrassa, Barcelona, Spain Recruiting -
Hospital de Burgos
Burgos, Burgos, Spain Recruiting -
H. Provincial de Castellón
Castelló, Castelló, Spain Recruiting -
Hospital General La Mancha Centro
Alcázar de San Juan, Ciudad Real, Spain Recruiting -
Hospital General Universitario de Ciudad Real
Ciudad Real, Ciudad Real, Spain Recruiting -
Complejo Hospitalario de la Coruña
A Coruña, Coruña, Spain Recruiting -
Hospital Virgen de la Luz
Cuenca, Cuenca, Spain Recruiting -
Hospital San Pedro de Alcántara
Cáceres, Cáceres, Spain Recruiting -
Hospital Dr. Josep Trueta
Girona, Girona, Spain Recruiting -
H. Insular de Gran Canarias
Las Palmas de Gran Canaria, Gran Canarias, Spain Recruiting -
H. Virgen de las Nieves
Granada, Granada, Spain Recruiting -
Oncogranada
Granada, Granada, Spain Recruiting -
Hospital Universitari de Guadalajara
Guadalajara, Guadalajara, Spain Recruiting -
Hospital de Jaén
Jaén, Jaén, Spain Recruiting -
Complejo Asistencial Universitario de León
León, León, Spain Recruiting -
Hospital Universitario Lucus Augusti
Lugo, Lugo, Spain Recruiting -
Hospital Príncipe de Asturias
Alcalá de Henares, Madrid, Spain Recruiting -
Hospital Universitario Fundación Alcorcón
Alcorcón, Madrid, Spain Recruiting -
Hospital HLA Moncloa
Aravaca, Madrid, Spain Recruiting -
H. Fuenlabrada
Fuenlabrada, Madrid, Spain Recruiting -
Hospital La Princesa
Madrid, Madrid, Spain Recruiting -
H.U. Puerta de Hierro
Madrid, Madrid, Spain Recruiting -
Fundación Jimenez Diaz
Madrid, Madrid, Spain Recruiting -
Imoncology
Madrid, Madrid, Spain Recruiting -
Hospital Universitario Sanchinarro
Madrid, Madrid, Spain Recruiting -
Hospital Universitario Infanta Sofía
Madrid, Madrid, Spain Recruiting -
H. Clínico San Carlos
Madrid, Madrid, Spain Recruiting -
H. La Paz
Madrid, Madrid, Spain Recruiting -
Hospital General Universitario Gregorio Marañón
Madrid, Madrid, Spain Recruiting -
Hospital Universitario de Móstoles
Móstoles, Madrid, Spain Recruiting -
Hospital Universitario Infanta Cristina
Parla, Madrid, Spain Recruiting -
Hospital Universitario Quirón Madrid
Pozuelo de Alarcón, Madrid, Spain Recruiting -
Hospital General Universitario Santa Lucía
Cartagena, Murcia, Spain Recruiting -
H. Morales Messeguer
Murcia, Murcia, Spain Recruiting -
Hospital Clínico Universitario Virgen de la Arrixaca
Murcia, Murcia, Spain Recruiting -
Hospital Quirón Salud Málaga
Málaga, Málaga, Spain Recruiting -
H. Carlos Haya
Málaga, Málaga, Spain Recruiting
+29 more sites. See ClinicalTrials.gov for the full list.
Study contacts
- Principal investigator: Mariano Provencio, MD — Hospital Puerta del Hierro
- Study coordinator: Eva Pereira
- Email: epereira@gecp.org
- Phone: +34934302006
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Community- or home-based exercise for adults with weakened heart or lungs
This test will see if an eight-week, community- or home-based exercise program can improve heart and lung function in adults 18–85 with reduced cardiopulmonary fitness.
-
Robotic bronchoscopic ablation for small peripheral lung tumors
This registry collects information on people with primary or metastatic peripheral lung tumors who have robotic-assisted bronchoscopic ablation to see how safe the procedure is and how well it controls tumors.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.